159 related articles for article (PubMed ID: 16183290)
1. Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 6-bromo-5-hydroxy-1H-indole-3-carboxylates.
Chai H; Zhao Y; Zhao C; Gong P
Bioorg Med Chem; 2006 Feb; 14(4):911-7. PubMed ID: 16183290
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 5-hydroxy-1H-indole-3-carboxylates.
Zhao C; Zhao Y; Chai H; Gong P
Bioorg Med Chem; 2006 Apr; 14(8):2552-8. PubMed ID: 16326106
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in-vitro anti-hepatitis B virus activity of ethyl 6-bromo-8-hydroxyimidazo[1,2-a]pyridine-3-carboxylates.
Chen D; Liu Y; Zhang S; Guo D; Liu C; Li S; Gong P
Arch Pharm (Weinheim); 2011 Mar; 344(3):158-64. PubMed ID: 21384414
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and anti-hepatitis C virus activity of novel ethyl 1H-indole-3-carboxylates in vitro.
Sellitto G; Faruolo A; de Caprariis P; Altamura S; Paonessa G; Ciliberto G
Bioorg Med Chem; 2010 Aug; 18(16):6143-8. PubMed ID: 20638289
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and anti-HBV activities evaluation of new ethyl 8-imidazolylmethyl-7-hydroxyquinoline-3-carboxylate derivatives in vitro.
Liu Y; Zhao Y; Zhai X; Liu X; Sun L; Ren Y; Gong P
Arch Pharm (Weinheim); 2008 Jul; 341(7):446-52. PubMed ID: 18574853
[TBL] [Abstract][Full Text] [Related]
6. Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.
Kumar R; Semaine W; Johar M; Tyrrell DL; Agrawal B
J Med Chem; 2006 Jun; 49(12):3693-700. PubMed ID: 16759112
[TBL] [Abstract][Full Text] [Related]
7. Identification of novel 5-hydroxy-1H-indole-3-carboxylates with anti-HBV activities based on 3D QSAR studies.
Chai HF; Liang XX; Li L; Zhao CS; Gong P; Liang ZJ; Zhu WL; Jiang HL; Luo C
J Mol Model; 2011 Aug; 17(8):1831-40. PubMed ID: 21053034
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and anti-hepatitis B virus activities of Matijing-Su derivatives.
Xu B; Huang Z; Liu C; Cai Z; Pan W; Cao P; Hao X; Liang G
Bioorg Med Chem; 2009 Apr; 17(8):3118-25. PubMed ID: 19307124
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of Matijing-Su derivatives as potent anti-HBV agents.
Qiu J; Xu B; Huang Z; Pan W; Cao P; Liu C; Hao X; Song B; Liang G
Bioorg Med Chem; 2011 Sep; 19(18):5352-60. PubMed ID: 21872478
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antiviral activity of new acrylamide derivatives containing 1,2,3-thiadiazole as inhibitors of hepatitis B virus replication.
Dong WL; Liu ZX; Liu XH; Li ZM; Zhao WG
Eur J Med Chem; 2010 May; 45(5):1919-26. PubMed ID: 20149495
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in-vitro anti-hepatitis-B virus activity of 6H-[1]benzothiopyrano[4,3-b] quinolin-10-ols.
Jia W; Zhao Y; Li R; Wu Y; Li Z; Gong P
Arch Pharm (Weinheim); 2009 Sep; 342(9):507-12. PubMed ID: 19637181
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and anti-hepatitis B virus evaluation of novel ethyl 6-hydroxyquinoline-3-carboxylates in vitro.
Liu Y; Zhao Y; Zhai X; Feng X; Wang J; Gong P
Bioorg Med Chem; 2008 Jul; 16(13):6522-7. PubMed ID: 18524601
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and evaluation of novel phenyl propionamide derivatives as non-nucleoside hepatitis B virus inhibitors.
Qiu J; Gong Q; Gao J; Chen W; Zhang Y; Gu X; Tang D
Eur J Med Chem; 2018 Jan; 144():424-434. PubMed ID: 29288943
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological evaluation and structure-activity relationships of glycyrrhetinic acid derivatives as novel anti-hepatitis B virus agents.
Wang LJ; Geng CA; Ma YB; Huang XY; Luo J; Chen H; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2012 May; 22(10):3473-9. PubMed ID: 22520261
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of hemslecin A derivatives: a new class of hepatitis B virus inhibitors.
Guo RH; Geng CA; Huang XY; Ma YB; Zhang Q; Wang LJ; Zhang XM; Zhang RP; Chen JJ
Bioorg Med Chem Lett; 2013 Mar; 23(5):1201-5. PubMed ID: 23385212
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of 1H-benzimidazol-5-ols as potent HBV inhibitors.
Zhao Y; Liu Y; Chen D; Wei Z; Liu W; Gong P
Bioorg Med Chem Lett; 2010 Dec; 20(24):7230-3. PubMed ID: 21074429
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of hepatitis B virus (HBV) replication by pyrimidines bearing an acyclic moiety: effect on wild-type and mutant HBV.
Semaine W; Johar M; Tyrrell DL; Kumar R; Agrawal B
J Med Chem; 2006 Mar; 49(6):2049-54. PubMed ID: 16539393
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships study of 6-chloro-4-(2-chlorophenyl)-3-(2-hydroxyethyl) quinolin-2(1H)-one derivatives as novel non-nucleoside anti-hepatitis B virus agents.
Guo RH; Zhang Q; Ma YB; Luo J; Geng CA; Wang LJ; Zhang XM; Zhou J; Jiang ZY; Chen JJ
Eur J Med Chem; 2011 Jan; 46(1):307-19. PubMed ID: 21145140
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anti-hepatitis B virus and anti-hepatitis C virus activities of 7-deazaneplanocin A analogues in vitro.
Kim HJ; Sharon A; Bal C; Wang J; Allu M; Huang Z; Murray MG; Bassit L; Schinazi RF; Korba B; Chu CK
J Med Chem; 2009 Jan; 52(1):206-13. PubMed ID: 19072694
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of erythrocentaurin derivatives as a new class of hepatitis B virus inhibitors.
Geng CA; Huang XY; Ma YB; Zhang XM; Chen JJ
Bioorg Med Chem Lett; 2015 Apr; 25(7):1568-71. PubMed ID: 25737009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
